Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Transboundary and Emerging Diseases is Scopus-indexed (Q1, CiteScore 8.2), WoS SCIE. It is covered by India's One Nation One Subscription scheme, which pays the article processing charge for authors at eligible institutions. Published by John Wiley and Sons Ltd.
Checked against the index lists dated .
ISSN 1865-1674Verify ISSN ↗1865-1682Verify ISSN ↗
Publisher: John Wiley and Sons Ltd
Cost to publish: APC covered for authors at ONOS-subscribed Indian institutions
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Veterinary (all) | 3 / 204 | 98th | Q1 |
| Immunology and Microbiology (all) | 8 / 63 | 88th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription)
Yes — actively indexed in Scopus, coverage 2008–present, best quartile Q1, CiteScore 8.2.
Transboundary and Emerging Diseases is Q1 in Veterinary (all) (rank 3 of 204) and Q1 in Immunology and Microbiology (all) (rank 8 of 63), by CiteScore 2025.
Transboundary and Emerging Diseases is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 8.2, which places it in quartile Q1 at the 98th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.865, quartile Q1, with an H-index of 100.
For authors at Indian institutions covered by One Nation One Subscription (ONOS), the article processing charge is paid by the scheme. The publisher lists an article processing charge of about US$2,710 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Transboundary and Emerging Diseases is published by John Wiley and Sons Ltd. Its print ISSN is 1865-1674 and its online ISSN is 1865-1682.
Yes. ONOS also covers its article processing charge for authors at eligible institutions.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Transboundary and Emerging Diseases has an h-index of 111 and a 2-year mean of 2.73 citations per paper (OpenAlex). Its Scopus CiteScore is 8.2, quartile Q1. On 2-year citations it ranks #16 of 197 Scopus journals in Veterinary (all).
Transboundary and Emerging Diseases published 257 papers in 2025; its busiest recent year was 2020 with 517. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2026), authors are most often from China (51.1%), United States (6.3%) and United Kingdom (4.1%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 6 retracted papers are recorded (1.5 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.